mTOR enhancement of STIM1-mediated store-operated Ca~(2+) signaling constrains tumor development
【摘要】:正RTK-PI3K-AKT-TSC1/TSC2-mTOR pathway is frequently dysregulated in cancer. Loss-of-function mutations in either the TSCl or TSC2 tumor suppressor gene cause Tuberous Sclerosis Complex(TSC),an autosomal dominant disorder featured with benign tumors in multiple organs.TSC l and TSC2 form a protein complex as a key negative regulator of mTOR.Even though hyperactive mTOR signal ing drives tumor development.the critical effectors downstream of mTOR leading to tumor growth are
|
|
|
|
1 |
梁霄;何芳;;STIM和Orai在钙库操纵的钙内流途径及心脑血管疾病中的作用[J];生命的化学;2011年03期 |
2 |
;[J];;年期 |
3 |
;[J];;年期 |
4 |
;[J];;年期 |
5 |
;[J];;年期 |
6 |
;[J];;年期 |
7 |
;[J];;年期 |
8 |
;[J];;年期 |
9 |
;[J];;年期 |
10 |
;[J];;年期 |
11 |
;[J];;年期 |
12 |
;[J];;年期 |
13 |
;[J];;年期 |
14 |
;[J];;年期 |
15 |
;[J];;年期 |
16 |
;[J];;年期 |
17 |
;[J];;年期 |
18 |
;[J];;年期 |
19 |
;[J];;年期 |
20 |
;[J];;年期 |
|